Document is current

Any future updates will be listed below

From extrapolation to evidence: BNT162b2 (Pfizer-BioNTech COVID-19 vaccine) safety and immunogenicity in adolescents with juvenile immune-mediated inflammatory disease

Crossref DOI link: https://doi.org/10.1038/s41390-026-05013-4

Published Online: 2026-04-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark